Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Cohance Lifesciences Ltd Financial Statements & Historical Data

Updated NSE: COHANCEBSE: 543064
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 2 October 2026, 9:36 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price451₹ per share
Reported P/E160Times
Book value per share102₹ per share
Reported ROCE5.81 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 2 October 2026, 9:36 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap17,267 Cr.
Current Price451
High / Low918/267
Stock P/E160
Book Value102
Dividend Yield0.00 %
ROCE5.81 %
ROE4.89 %
Face Value1.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Cohance Lifesciences Ltd 17,267 Cr. 451 918/267160 1020.00 %5.81 %4.89 % 1.00
Pfizer Ltd 17,654 Cr. 3,859 5,578/3,79223.0 9191.94 %24.1 %18.0 % 10.0
ERIS Lifesciences Ltd 16,507 Cr. 1,190 1,740/1,16325.2 2820.61 %14.1 %18.7 % 1.00
Natco Pharma Ltd 16,111 Cr. 821 1,217/78614.1 4700.61 %17.4 %17.1 % 2.00
Alembic Pharmaceuticals Ltd 16,025 Cr. 815 998/63521.5 2891.47 %12.6 %13.4 % 2.00
Industry Average17,573.63 Cr1,250.1655.08211.240.39%26.16%16.59%6.06

All Competitor Stocks of Cohance Lifesciences Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 348231220253488604676840549556545619422
Expenses 181133154180363398439611437435449520421
Operating Profit 16798667312520523722911212195991
OPM % 48%42%30%29%26%34%35%27%20%22%18%16%0.3%
Other Income 11201417191622-46161-1812
Interest 102210101110109997
Depreciation 13121317313844544544475150
Profit before tax 164105657110317420516163844120-43
Tax % 26%25%29%25%27%21%25%27%26%21%29%58%5%
Net Profit 121804753751381531174666298-45
EPS in Rs 4.743.131.842.102.965.446.014.731.281.940.960.51-0.63

Last Updated: September 29, 2026, 5:21 pm

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: October 2, 2026, 9:36 pm

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 3788341,0101,3201,3401,0512,6082,2692,142
Expenses 2064495677387666451,8111,8411,825
Operating Profit 172385443582574406797427316
OPM % 45%46%44%44%43%39%31%19%15%
Other Income 16668133466253411
Interest 323129137413734
Depreciation 122432394855167187192
Profit before tax 158405468668560406643207101
Tax % 31%22%23%32%27%26%25%27%
Net Profit 10931736245441130048415059
EPS in Rs 12.4514.2317.8316.1611.8019.144.682.78
Dividend Payout % 0%20%14%28%37%0%0%0%

YoY Net Profit Growth

Year2019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)190.83%14.20%25.41%-9.47%-27.01%61.33%-69.01%
Change in YoY Net Profit Growth (%)0.00%-176.63%11.22%-34.89%-17.54%88.34%-130.34%

Cohance Lifesciences Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2019-2020 to 2025-2026.

Growth

Compounded Sales Growth
10 Years:Not available
5 Years:8%
3 Years:-3%
TTM:64%
Compounded Profit Growth
10 Years:Not available
5 Years:-5%
3 Years:-16%
TTM:38%
Stock Price CAGR
10 Years:Not available
5 Years:22%
3 Years:23%
1 Year:-22%
Return on Equity
10 Years:Not available
5 Years:21%
3 Years:17%
Last Year:13%

Last Updated: September 5, 2025, 1:41 pm

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: October 2, 2026, 9:36 pm

MonthMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 0.0013252525252538
Reserves 5788321,1551,5021,7102,0253,6233,873
Borrowings 83186143977065486400
Other Liabilities 1231421512051601381,3461,415
Total Liabilities 7831,1731,4741,8301,9662,2545,4805,727
Fixed Assets 2713574415346636703,1073,369
CWIP 1111029630165179334178
Investments 7338542598536904337529
Other Assets 3943763956676015011,7021,652
Total Assets 7831,1731,4741,8301,9662,2545,4805,727
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 50407383330457358673368
Cash from Investing Activity + -65-413-311-136-195-362-388-251
Cash from Financing Activity + 267-76-156-242-14-327-165
Net Cash Flow 111-53720-18-42-48
Free Cash Flow -6304272255171307357169
CFO/OP 49%128%111%88%105%115%107%102%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow-6.00304.00272.00255.00171.00307.00357.00169.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 142513765304687
Inventory Days 556278243259279268199
Days Payable 19011310097634996
Cash Conversion Cycle 509217180228247265190
Working Capital Days 20564561089910874
ROCE %50%40%41%32%19%15%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 60.00%60.00%50.10%50.10%50.10%50.10%50.10%66.41%57.49%57.49%57.49%57.49%
FIIs 10.01%10.14%9.54%9.80%10.70%10.84%11.05%7.23%6.51%6.01%5.59%6.50%
DIIs 14.13%15.94%17.24%17.42%16.95%16.67%16.60%11.40%20.81%21.57%21.79%20.09%
Government 0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.01%
Public 15.85%13.93%23.11%22.67%22.26%22.37%22.24%14.95%15.16%14.91%15.11%15.92%
No. of Shareholders 73,71570,05268,93265,77769,33784,21086,32580,91075,28481,87785,23099,149
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund 6,121,393 4.44 295.826,081,3732026-06-11 07:20:150.66%
Invesco India Contra Fund 4,013,973 1 193.983,598,5112026-06-11 07:20:1611.55%
DSP ELSS Tax Saver Fund 3,285,254 0.97 158.761,910,0662025-12-07 02:39:3072%
DSP Healthcare Fund 3,140,630 4.83 151.772,972,2132026-06-11 07:20:165.67%
DSP Aggressive Hybrid Fund 2,808,197 1.17 135.71N/AN/AN/A
DSP Large & Mid Cap Fund 2,762,648 0.77 133.51N/AN/AN/A
DSP Flexi Cap Fund 2,453,891 1.01 118.581,830,5352025-12-07 02:39:3034.05%
ICICI Prudential India Opportunities Fund 2,377,398 0.32 114.89N/AN/AN/A
Bandhan Small Cap Fund 2,331,139 0.44 112.652,160,1392026-03-24 01:19:437.92%
ICICI Prudential Value Fund 2,301,367 0.19 111.213,263,0912026-06-11 07:20:16-29.47%

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Distributions & retention

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.001.001.001.00
Basic EPS (Rs.) 10.5211.8016.1617.8314.23
Diluted EPS (Rs.) 10.4511.8016.1617.8314.23
Cash EPS (Rs.) 13.4413.9418.0317.7513.37
Book Value[Excl.RevalReserv]/Share (Rs.) 66.6480.5668.1659.9946.39
Book Value[Incl.RevalReserv]/Share (Rs.) 66.6480.5668.1659.9946.39
Revenue From Operations / Share (Rs.) 47.0441.3052.6551.8639.66
PBDIT / Share (Rs.) 17.0418.3724.0826.3917.86
PBIT / Share (Rs.) 13.9916.2322.2024.8516.62
PBT / Share (Rs.) 13.5115.9421.9924.6116.26
Net Profit / Share (Rs.) 10.4011.8016.1616.2112.12
NP After MI And SOA / Share (Rs.) 10.5211.8016.1617.8314.23
PBDIT Margin (%) 36.2144.4845.7250.8845.03
PBIT Margin (%) 29.7439.2942.1647.9241.90
PBT Margin (%) 28.7138.5841.7647.4540.99
Net Profit Margin (%) 22.1028.5630.6831.2530.56
NP After MI And SOA Margin (%) 22.3628.5630.6834.3735.88
Return on Networth / Equity (%) 15.7814.6423.7029.7130.68
Return on Capital Employeed (%) 13.3619.2431.2739.0733.71
Return On Assets (%) 8.8313.3220.9224.8024.57
Long Term Debt / Equity (X) 0.000.000.000.010.03
Total Debt / Equity (X) 0.040.010.040.060.11
Asset Turnover Ratio (%) 0.450.490.700.800.79
Current Ratio (X) 2.4311.826.375.362.57
Quick Ratio (X) 1.989.654.404.021.66
Inventory Turnover Ratio (X) 6.023.871.441.901.65
Dividend Payout Ratio (NP) (%) 0.000.0049.5122.437.02
Dividend Payout Ratio (CP) (%) 0.000.0044.3620.656.46
Earning Retention Ratio (%) 0.000.0050.4977.5792.98
Cash Earning Retention Ratio (%) 0.000.0055.6479.3593.54
Interest Coverage Ratio (X) 35.1262.77112.74107.8249.73
Interest Coverage Ratio (Post Tax) (X) 22.4441.3076.6667.2334.75
Enterprise Value (Cr.) 29662.0317211.9412039.3615779.1112742.73
EV / Net Operating Revenue (X) 24.7716.378.9811.9512.62
EV / EBITDA (X) 68.3836.8019.6423.4928.02
MarketCap / Net Operating Revenue (X) 24.6616.388.9811.9212.49
Retention Ratios (%) 0.000.0050.4877.5692.97
Price / BV (X) 17.408.406.9310.3010.68
Price / Net Operating Revenue (X) 24.6616.388.9811.9212.49
EarningsYield 0.010.010.030.020.02
Advertisements
Explore Industry-wise Company financial data